Top

Journal of Assisted Reproduction and Genetics

Published in:

01-09-2018 | Assisted Reproduction Technologies

Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes

Authors: Yoni Cohen, Alexandra St-Onge-St-Hilaire, Samer Tannus, Grace Younes, Michael H. Dahan, William Buckett, Weon-Young Son

Published in: Journal of Assisted Reproduction and Genetics | Issue 9/2018

Abstract

Purpose

To assess effects on fertilization rate, embryo quality, pregnancy, and live birth rates of vitrification and warming of oocytes that matured in vitro (vIVM) compared to fresh in vitro maturation (fIVM) cycles.

Methods

A retrospective cohort study conducted at a university hospital-affiliated IVF unit. Fifty-six cycles of vIVM cycles and 263 fIVM in women diagnosed with polycystic ovarian syndrome (PCOS) ovaries were included in the analysis. The study group included PCOS patients who failed ovulation induction with intrauterine insemination and were offered IVM cycle followed by oocyte vitrification and warming. The embryological aspects and clinical outcomes were compared to those of controls undergoing fresh IVM cycles during the same period. The main outcome measure was live birth rate.

Results

One thousand seventy oocytes were collected from 56 patients and underwent vitrification and warming. In the control group, 4781 oocytes were collected from 219 patients who had undergone a fresh IVM cycle. Oocyte maturation rates were similar between the groups (mean ± SD: 0.7 ± 0.2 vs. 0.6 ± 0.2, for vIVM and fIVM, respectively). Survival rate after warming was 59.8%. Fertilization and embryo cleavage rates per oocyte were significantly lower in the vIVM group. Clinical pregnancy (10.7 vs. 36.1%) and live birth rates (8.9 vs. 25.9%) per cycle were significantly lower in the vIVM group than those in the fIVM group (P = 0.005 and P < 0.001, respectively). Five healthy babies were born in the vIVM group.

Conclusions

The reproductive potential of vitrified IVM oocytes is impaired. This injury likely occurs through vitrification and warming.

Liu J, Lu G, Qian Y, Mao Y, Ding W. Pregnancies and births achieved from in vitro matured oocytes retrieved from poor responders undergoing stimulation in in vitro fertilization cycles. Fertil Steril. 2003;80:447–9.CrossRefPubMed

De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014;384:1302–10.CrossRefPubMedPubMedCentral

Creux H, Monnier P, Son WY, Tulandi T, Buckett W. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. Fertil Steril. 2017;107:198–204.CrossRefPubMed

Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, et al. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy. Hum Reprod. 2016;31:750–62.CrossRefPubMed

Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105:755–764e8.CrossRefPubMed

Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod BioMed Online. 2005;11:300–8.CrossRefPubMed

Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod BioMed Online. 2010;21:566–71.CrossRefPubMed

Ali A, Benkhalifa M, Miron P. In-vitro maturation of oocytes: biological aspects. Reprod BioMed Online. 2006;13:437–46.CrossRefPubMed

Sanfins A, Plancha CE, Overstrom EW, Albertini DF. Meiotic spindle morphogenesis in in vivo and in vitro matured mouse oocytes: insights into the relationship between nuclear and cytoplasmic quality. Hum Reprod. 2004;19:2889–99.CrossRefPubMed

10.

Walls ML, Ryan JP, Keelan JA, Hart R. In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts. Hum Reprod. 2015;30:1842–9.CrossRefPubMed

11.

Walls ML, Hart R, Keelan JA, Ryan JP. Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization. Fertil. Steril. 2016;106:1392–1398.e5.CrossRefPubMed

12.

Brambillasca F, Guglielmo MC, Coticchio G, Mignini Renzini M, Dal Canto M, Fadini R. The current challenges to efficient immature oocyte cryopreservation. J Assist Reprod Genet. 2013;30:1531–9.CrossRefPubMedPubMedCentral

13.

Lei T, Guo N, Liu J-Q, Tan M-H, Li Y-F. Vitrification of in vitro matured oocytes: effects on meiotic spindle configuration and mitochondrial function. Int J Clin Exp Pathol. 2014;7:1159–65.PubMedPubMedCentral

14.

Chian RC, Huang JYJ, Gilbert L, Son WY, Holzer H, Cui SJ, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91:2391–8.CrossRefPubMed

15.

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.CrossRef

16.

Son WY, Chung JT, Demirtas E, Holzer H, Sylvestre C, Buckett W, et al. Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved. Reprod BioMed Online. 2008;17:59–67.CrossRefPubMed

17.

Son WY, Tan SL. Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Hum Reprod Update. 2010;16:675–89.CrossRefPubMed

18.

Shalom-Paz E, Holzer H, Young Son W, Levin I, Tan SL, Almog B. PCOS patients can benefit from in vitro maturation (IVM) of oocytes. Eur J Obstet Gynecol Reprod Biol. 2012;165:53–6.CrossRefPubMed

19.

Cao Y, Xing Q, Zhang Z-G, Wei Z-L, Zhou P, Cong L. Cryopreservation of immature and in-vitro matured human oocytes by vitrification. Reprod BioMed Online. 2009;19:369–73.CrossRefPubMed

20.

Fasano G, Demeestere I, Englert Y. In-vitro maturation of human oocytes: before or after vitrification? J Assist Reprod Genet. 2012;29:507–12.CrossRefPubMedPubMedCentral

21.

Wang H, Racowsky C, Combelles CMH. Is it best to cryopreserve human cumulus-free immature oocytes before or after in vitro maturation? Cryobiology. 2012;65:79–87.CrossRefPubMed

22.

Benkhalifa M, Demirol A, Menezo Y, Balashova E, Abduljalil AK, Abbas S, et al. Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study. ReprodBiomedOnline. 2009;18:29–36.

23.

Druckenmiller S, Goldman KN, Labella PA, Fino ME, Bazzocchi A, Noyes N. Successful oocyte cryopreservation in reproductive-aged cancer survivors. Obstet Gynecol. 2016;127:474–80.CrossRefPubMed

24.

Cooper A, Paynter SJ, Fuller BJ, Shaw RW. Differential effects of cryopreservation on nuclear or cytoplasmic maturation in vitro in immature mouse oocytes from stimulated ovaries. Hum Reprod. 1998;13:971–8.CrossRefPubMed

25.

Hu W, Marchesi D, Qiao J, Feng HL. Effect of slow freeze versus vitrification on the oocyte: an animal model. Fertil Steril. 2012;98:752–760.e3.CrossRefPubMed

26.

Matson PL, Graefling J, Junk SM, Yovich JL, Edirisinghe WR. Cryopreservation of oocytes and embryos: use of a mouse model to investigate effects upon zona hardness and formulate treatment strategies in an in-vitro fertilization programme. Hum Reprod. 1997;12:1550–3.CrossRefPubMed

27.

Gook DA, Osborn SM, Johnston WI. Cryopreservation of mouse and human oocytes using 1,2-propanediol and the configuration of the meiotic spindle. Hum Reprod. 1993;8:1101–9.CrossRefPubMed

28.

Huang JYJ, Chen HY, Park JYS, Tan SL, Chian RC. Comparison of spindle and chromosome configuration in in vitro- and in vivo-matured mouse oocytes after vitrification. Fertil Steril. 2008;90:1424–32.CrossRefPubMed

29.

Prasath EB, Chan MLH, Wong WHW, Lim CJW, Tharmalingam MD, Hendricks M, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod. 2014;29:276–8.CrossRefPubMed

30.

Uzelac PS, Delaney AA, Christensen GL, Bohler HCL, Nakajima ST. Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years. Fertil Steril. 2015;104:1258–60.CrossRefPubMed

31.

Dahan MH, Tan SL, Chung J, Son WY. Clinical definition paper on in vitro maturation of human oocytes. Hum Reprod. 2016;31:1383–6.CrossRefPubMed

Title: Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes
Authors: Yoni Cohen
Alexandra St-Onge-St-Hilaire
Samer Tannus
Grace Younes
Michael H. Dahan
William Buckett
Weon-Young Son
Publication date: 01-09-2018
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 9/2018
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-018-1216-3

ACC 2024 Congress

Springer Medicine

Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2018

The cost of a euploid embryo identified from preimplantation genetic testing for aneuploidy (PGT-A): a counseling tool

Low estradiol responses in oocyte donors undergoing gonadotropin stimulation do not influence clinical outcomes

Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases—an analysis of 992 stimulations

Correction to: Factors associated with short interpregnancy interval among women treated with in vitro fertilization

Euploid embryos selected by an automated time-lapse system have superior SET outcomes than selected solely by conventional morphology assessment

Factors associated with short interpregnancy interval among women treated with in vitro fertilization